Germany· DE-A57-eeb270e045a2de81
Exoderil
A naftifine product containing naftifine hydrochloride, registered in Germany by Medice Pharma Gmbh & Co. Kg. The same ATC class is registered in 4 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Naftifine is registered in 4 of 19 countries.
Countries holding a registration under ATC D01AE22 (naftifine), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
- 3 of them publish a price we can compare per daily dose
Naftifine · ATC D01AE22
4 / 19 countries
- Czechiaprice
- Germany
- Polandprice
- United Statesprice
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Naftifine Hydrochloride
- Manufacturer
- Medice Pharma Gmbh & Co. Kg
- Country
- Germany (DE)
- ATC code
- D01AE22
- ATC class
- Naftifine
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Naftifine in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaEXODERILSandoz GmbH, Kundl
- United StatesNaftifine HydrochlorideSun Pharmaceutical Industries, Inc.
- PolandExoderilSandoz GmbH
Authorised across Europe · EMA
The same active substance is authorised in 11 EEA countries. Names it is sold under:
- Austria · Exoderil
- Bulgaria · Exoderil, Екзодерил
- Czechia · Exoderil, Videril
- Estonia · Exoderil
- Croatia · Atlex 10 Mg/Ml Sprej Za Kožu, Exoderil
- Hungary · Exoderil
- Italy · Suadian
- Lithuania · Exoderil
- Latvia · Exoderil
- Romania · Exoderil, Naftifina Atb
- Slovenia · Exoderil
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/5024457c-d2c9-4a01-a9d6-127cf49c950a GET /v1/drugs/5024457c-d2c9-4a01-a9d6-127cf49c950a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Cutaneous Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Naftifine Hydrochloride",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about naftifine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.